COMMUNIQUÉS West-GlobeNewswire

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes
05/06/2025
CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal [...]
Merus N.V. annonce la fixation du prix de l’offre publique d’actions ordinaires
05/06/2025
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 05 juin 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus », la « Société », « nous » ou « notre/nos », une société spécialisée dans l’oncologie [...]
Valneva annonce des résultats positifs de Phase 2 à six mois sur la persistance des anticorps et l’innocuité de son vaccin à dose unique contre le chikungunya IXCHIQ® chez les enfants
05/06/2025
IXCHIQ ® a été bien toléré par les enfants âgés d’un à onze ans indépendamment de la dose de vaccin reçue (dose complète ou demi-dose) ou d’une précédente infection au virus du chikungunya Les niveaux d’anticorps [...]
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
05/06/2025
IXCHIQ ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more robust [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
05/06/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 5 juin 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général [...]
Safe Group annonce l’obtention du 510(k) de la FDA pour la solution Frida de SpineUp
05/06/2025
Safe Group annonce l’obtention du 510(k) de la FDA pour la solution Frida de SpineUp Fleurieux-sur-l’Arbresle - France - le 5 juin 2025 à 18h . Safe Group, acteur de référence dans le domaine des dispositifs médicaux [...]
Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal
05/06/2025
PALO ALTO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid [...]
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
05/06/2025
PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
The Foundation for Sarcoidosis Research and American Thoracic Society Announce Dr. Mark Mallozzi as the New FSR/ATS Partner Grant Awardee
05/06/2025
CHICAGO, June 05, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) and the American Thoracic Society (ATS) are pleased to announce that Mark Mallozzi, MD, MPH has been selected to receive the 2025 [...]
Roquette nomme Thierry Fournier au poste de Directeur Général
05/06/2025
Roquette nomme Thierry Fournier au poste de Directeur Général Lille, France, 5 juin 2025 - Roquette, un leader mondial des ingrédients d’origine végétale et des excipients pharmaceutiques destinés aux secteurs de la [...]
Roquette Appoints Thierry Fournier as Chief Executive Officer
05/06/2025
Roquette Appoints Thierry Fournier as Chief Executive Officer Lille, France, June 5, 2025 - Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for health, nutrition and bio industrial [...]
MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements
05/06/2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM” or the “Company”), today announced that on June 4, 2025, it [...]
DIOSynVax Presents Its Technology at the Invitation-Only Next Venture Capital Unit (VCU) Health Tech Showcase at the London Stock Exchange
05/06/2025
CAMBRIDGE, United Kingdom and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing safe, innovative, broadly protective vaccines presented its [...]
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
05/06/2025
Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods ® IBS Test. Gastroenterology , the premier journal in gastrointestinal science, features data [...]
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
05/06/2025
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL) and transformed [...]
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
05/06/2025
HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced that it has been selected for inclusion in the [...]
TOMI Announces Appointment of David Vanston as Chief Financial Officer
05/06/2025
FREDERICK, Md., June 05, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the appointment [...]
Tria Federal Promotes Atchut Kanthamani to President, Opens New Maryland Office
05/06/2025
ARLINGTON, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Tria Federal has promoted Atchut Kanthamani to the new position of President. In this role, he will lead Tria's business growth and technology innovation teams. [...]
Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain
05/06/2025
Follow-on study (“PoC 2”) builds on initial success in pancreatic cancer pain Ethics committee authorization supports platform expansion into visceral cancer pain for proprietary ablation technology Expansion supports [...]

Pages